Vyome Holdings (HIND) Market Capitalization (2025 - 2026)
Vyome Holdings (HIND) posted Market Capitalization of $15.1 million for Q2 2026, little changed on a QoQ basis from $15.1 million in Q1 2026.
Analysis
Vyome Holdings (HIND) Market Capitalization (2025 - 2026) Analysis & Trends
Vyome Holdings has reported Market Capitalization for 2 years, with the latest figure at $15.1 million in Q2 2026.
- On a quarterly basis, Market Capitalization changed N/A year-over-year to $15.1 million in Q2 2026; TTM through Jun 2026 was $15.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $7.4 million, changed N/A from the prior year.
- Market Capitalization was $15.1 million for Q2 2026 at Vyome Holdings, roughly flat from $15.1 million in the prior quarter.
- The five-year high for Market Capitalization was $15.1 million in Q1 2026, with the low at $7.4 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn |
| 10 | Vyome Holdings | 14.46 Mn | 6.57 Mn | 11,658.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.09 Mn |
| Mar 31, 2026 | 15.09 Mn |
| Dec 31, 2025 | 7.44 Mn |
| Sep 30, 2025 | 14.29 Mn |